Traditional Food Puts Chemotherapy To Shame, New Study Reveals -Health & Beauty Informations. This article, entitled Traditional Food Puts Chemotherapy To Shame, New Study Reveals, we have prepared this article carefully for you so you can retrieve information therein. Hopefully you understand the contents of this article that we put under the category health, well, happy reading.

Title : Traditional Food Puts Chemotherapy To Shame, New Study Reveals
link : Traditional Food Puts Chemotherapy To Shame, New Study Reveals

Traditional Food Puts Chemotherapy To Shame, New Study Reveals

id = " A traditional food plant that has been used for thousands years to improve the health and well-being, is finally being validated by science. The results? It can be far superior to a chemotherapy agent with deadly side effects and questionable efficacy. Increasingly, an awareness of the power of traditional plants that are commonly used to prevent and even treat cancer is coming to the forefront. In fact, GreenMedInfo.com now houses one of the largest databases of open access on the issue, with more than 3,000 studies on the value of more than 650 natural substances such as chemopreventive and chemotherapeutic agents. Now, a powerful new study published in Biochemistry Molecular and Cellular provides evidence that a traditional food consumed in the tropics and vegetables - Morinda citrifolia (Noni) leaves - can be the ideal complementary therapy or functional foods in the prevention or treatment of lung cancer.

Surprisingly, the study found that an extract of noni leaf was more effective than chemotherapy drug Erlotinib in suppressing metastasis of lung cancer in an animal model. According to the study, lung cancer is the deadliest of all cancers in number worldwide, with 1.4 million lives a year. About 80% of these cases of lung cancer is classified as small-cell carcinoma (NSCLC) and conventional chemotherapy and / or radiotherapy it is notorious for not killing them because of the phenomena of chemoresistance and radioresistance. Survival statistics using these outdated methods are sad:

Chemotherapy and / or radiation usually fail because NSCLC cells are inherently resistant to them. Chemotherapy is quite ineffective for patients with advanced NSCLC with response rate of only 20-35% and a median survival of 10 to 12 months "

One of the most common interventions used for cancer lung today, on the side of chemotherapy, is the drug erlotinib, but the drug has not been proven safe or clinically effective in a controlled true placebo trial. it was approved by the FDA based on its ability to improve survival of some months when added to conventional chemotherapy only in relation to the use of chemotherapy alone tell about this very common practice of ignoring standards based on rigorous testing with another chemotherapy drug recently. costs ipilimumab 4,000 times more than then gold by weight; at most, only improves survival time in patients with malignant melanoma for a few months, and that has deadly side effects Read more :.. Chemo Drug capital costs 4,000x more than gold is clearly needed safer and more effective cheaper alternatives, and this latest study could open a much needed discussion the role of natural substances in the prevention and treatment of cancer.

leaf extract superior to chemotherapy noni in two experimental models

The new study, entitled, "the suppression of metastatic lung citrifolia leaf (Noni) cancer Morinda compared with erlotinib route, anti-inflammatories antioxidants responses and endogenous gene activation of apoptosis ", evaluated the effects macro and micro Noni leaves in the development of lung cancer metastatized in both a cellular and animal model compared to the chemotherapeutic agent approved by Erlotinib FDA. two types of lung cancer cells used :. Cells and human A549 alveolar epithelial basal lung cancer and cell lung carcinoma Lewis mouse In the model of cell extract "inhibits proliferation and induced apoptosis [programmed cell death] in A549 cells (IC50 = 23.47? G / ml) cells and mouse lung carcinoma Lewis of (LL2) (IC50 = 5.50? g / ml) in vitro, arrested cell cycle of cancer in G0 / G1 phases and significantly increased the caspase-3 / -8 without changing the levels of caspase-9. " essentially, noni leaf extract made changes consistent with what one would expect in a excellent agent chemotherapy. Perhaps most notably, the noni leaf extract exhibited no toxicity in normal lung cells MRC5 - something that chemotherapy and radiation are notoriously unable to produce. Said less euphemistically, chemotherapy and radiation not only drive cancer in a more invasive state, but can transform non-malignant cells in a highly malignant phenotype, including inducing stem-ness, a type of cell immortality which can mean a the death sentence that is induced. The next study to test the difference between the noni leaf extract and conventional chemotherapy agent erlotinib in a mouse model of lung non-small cell (NSCLC) cancer. Mice were fed with 150 and 300 mg / kg M. citrifolia leaf extract and compared to erlotinib (50 mg / kg body weight) for 21 days. It should be noted first that the adverse non-effect observed level (NOAEL) for Noni extract ethanol sheet it is an oral intake of 1000 mg / kg, indicating that the tested dose is well below what it could be used to demand the maximum therapeutic effects and results. Moreover, considering that Erlotinib has been proven to cause up to 50% of a test group of rats died of acute toxicity (LD50) at an oral dose of 1000 mg-2000 mg / kg. The results were reported as follows:

"the TRP53 pro-apoptotic genes were significantly increased, downregulated the tumor pro-genesis (BIRC5, JAK2 / STAT3 / STAT5A) genes in tumors of mice, significantly increased IL-4, IL-10 and NR3C1 antiinflammatory expression in the metastatic lung and liver cancer tissues and improve NFE2L2-dependent antioxidant responses against oxidative damage. the high extract neutrophil serum and reduced the concentration of red blood cells, hemoglobin, mean corpuscular volume and hemoglobin cell in the mammal induced lung cancer. inflammation and edema is deleted, and upregulated endogenous antioxidant responses to suppress apoptotic genes and cancer. "

the conclusion powerful comparison study was reported as follows:

" the / extract 300 mg kg was more effective than the 50 mg / kg Erlotinib for most of the parameters measured. "

Notably, a similar study was only published earlier this year with the same basic results: the leaf extract oral noni is superior to erlotinib in an animal model lung cancer. Chemotherapy ($ 220 per dose) versus Noni Leaf (12 cents per dose) The implications of this research are truly profound. Erlotinib (trade name Tarceva) can cost more than $ 7.700 per month (150 mg one day), depending on the dose of the drug used. Ironically, since the drug actually does not prolong survival effectively, salsa circulations dry trains profits sooner rather than later, because the patient dies. If indeed the drug prolongs survival of a year, would it be worth the 30,000 to 90,000 it costs? Perhaps, if you can afford it. When the price of noni leaf extract, which can cost as little as 12 cents per 250 mg of extract, you begin to see how skewed our concept of value is compared. How is it possible that a chemotherapy agent with deadly side effects, which can easily bankrupt a family if they are forced to pay out of pocket, is offered as the only option for people with cancer when something that is virtually free , safe, and has been shown effective in this way? Detractors and default skeptical that this is only "pre-clinical" research animals, and they say the results are not relevant to human physiology; at least not in a way that should inform our decisions regarding the prevention or treatment. While there are some truth in the gap times chasmic between animal and human physiology, the billion dollars plus pay wall between the pursuit of a compound of convincing for cancer lead and showing that it is effective through human clinical trials necessary for FDA approval of drugs is unsurpassed for an unpatentable substance as Noni. It simply would be no return on investment, and that is financial suicide, but also a legal violation of fiduciary responsibility has a funding organization to its shareholders. The figure indicated largely why animal studies as we reported here continue to fall short in both the interest and the funds necessary to demonstrate similar results in human clinical trials. Despite this, I think we have a constitutional right to the spiritual and physical self-possession and exercise of freedom of choice when it comes to all our health decisions. The concept that we need drug approval from the FDA or any other external authority, to consume a food or a plant to prevent, mitigate or treat any disease that we suffer, it is absurd from the point of view of human rights and basic medical ethical principles. For more information about why the FDA and the law prohibits the use of natural substances in medicine, read my article on the subject here. I also recently wrote an article about why the FDA will not allow turmeric, an anti-cancer highly compelling natural agent to be used in the prevention or treatment of cancer. Finally, to learn more about the amazing properties of Noni, take a look at the page GreenMedInfo.com based data on the subject here, where research cataloged in more than 50 potential applications is for the health of this amazing traditional food and medicinal herb ..
(source)

Thanks for Reading Traditional Food Puts Chemotherapy To Shame, New Study Reveals

Thank you for reading this Traditional Food Puts Chemotherapy To Shame, New Study Reveals, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article Traditional Food Puts Chemotherapy To Shame, New Study Reveals Url Address https://healthnbeautyarticles.blogspot.com/2016/07/traditional-food-puts-chemotherapy-to.html